Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
600329
Rang in aandelen
#4374
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, along with its... Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, along with its subsidiaries, primarily manufactures and markets traditional Chinese medicine, Western pharmaceuticals, and various healthcare products within the People's Republic of China. Its business activities are structured into two distinct divisions: Chinese Medicine and Western Medicine. The company's operations extend beyond its core offerings to include the production and distribution of Chinese, Western, and biological pharmaceutical items. It also engages in the wholesale and retail trade of medicines, biochemical pharmaceutical products, and everyday consumer goods, in addition to managing hospitals. Furthermore, Tianjin Pharmaceutical Da Ren Tang provides a comprehensive suite of services such as logistics, inventory management, equipment installation, and drug processing. It also offers pharmaceutical inspection, testing, and advisory services. In terms of its commercial model, the company supplies its proprietary branded medicinal products directly to wholesalers. Conversely, it acquires pharmaceuticals marketed under other brands from distributors, subsequently reselling these to other wholesale clients. Established in 1992 and based in Tianjin, People's Republic of China, the company was previously known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited before adopting its current name in May 2022.
Aandeelprijs
$6.17
Marktkapitalisatie
$3.52B
Verandering (1 dag)
-0.05%
Verandering (1 jaar)
-1.86%
Land
CN
Handel Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (600329)
Categorie
Healthcare
Operationele marge voor Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (600329)
Operationele marge op October 2026 TTM: 18.33%
Volgens de meest recente financiële rapporten en aandelenkoers van Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited is de huidige operationele marge (TTM) 18.33%. Eind 2024 had het bedrijf een operationele marge van 35.13%.
Geschiedenis van de operationele marge van Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited van 2001 tot 2026
Operationele marge aan het einde van elk jaar
| Jaar | Operationele Marge | Wijzigen |
|---|---|---|
| 2026 (TTM) | 18.33% | -63.80% |
| 2025 | 50.63% | 44.12% |
| 2024 | 35.13% | 163.34% |
| 2023 | 13.34% | 12.29% |
| 2022 | 11.88% | -5.34% |
| 2021 | 12.55% | 5.55% |
| 2020 | 11.89% | 9.59% |
| 2019 | 10.85% | 7.53% |
| 2018 | 10.09% | 9.08% |
| 2017 | 9.25% | 32.33% |
| 2016 | 6.99% | -0.85% |
| 2015 | 7.05% | 20.93% |
| 2014 | 5.83% | -13.50% |
| 2013 | 6.74% | 24.58% |
| 2012 | 5.41% | -12.46% |
| 2011 | 6.18% | -10.82% |
| 2010 | 6.93% | -4.55% |
| 2009 | 7.26% | 83.33% |
| 2008 | 3.96% | -167.69% |
| 2007 | -5.85% | -65.20% |
| 2006 | -16.81% | -1,112.65% |
| 2005 | 1.66% | -47.30% |
| 2004 | 3.15% | -30.46% |
| 2003 | 4.53% | -18.23% |
| 2002 | 5.54% | 4.92% |
| 2001 | 5.28% | 0.00% |
Operationele marge van vergelijkbare bedrijven of concurrenten
| Bedrijf | Operationele Marge | Verschil in operationele marge | Land |
|---|---|---|---|
| 0.00% | - |
DE
|
|
| 0.00% | - |
DE
|
|
| 10.52% | -99.43% |
JP
|
|
| 17.08% | -99.07% |
CH
|
|
| 22.93% | -98.75% |
IN
|
Wat is de Operationele marge van een bedrijf?
De Operationele marge is een belangrijke indicator om de winstgevendheid van een bedrijf te beoordelen. Hogere operationele marges zijn over het algemeen beter omdat ze aangeven dat een bedrijf zijn producten of diensten veel duurder kan verkopen dan de productiekosten. De Operationele marge wordt berekend door de winst van een bedrijf te delen door de omzet.